Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Important funding for nanomedicine research to improve diagnosis and treatment

Abstract:
Seven new research projects on regenerative medicine and nanomedicine received $16 million in funding. The studies, co-funded by the Canadian Institutes of Health Research (CIHR) and the Canadian Space Agency (CSA), were announced today at the University of Toronto by Dr. Colin Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific Director of the Canadian Institutes of Health Research Institute of Musculoskeletal Health and Arthritis; Mr. Gilles Leclerc, Director General, Space Exploration at the Canadian Space Agency; and Professor Peter Lewis, Associate Vice President (Research) at the University of Toronto. "The Government of Canada is proud to support regenerative medicine and nanomedicine projects that will translate into improved health for Canadians," said Dr. Carrie. "The knowledge that emerges from these research projects could also have wide ranging social and economic benefits."

Important funding for nanomedicine research to improve diagnosis and treatment

Toronto, Canada | Posted on March 17th, 2011

"CIHR is delighted to partner with the Canadian Space Agency to support research aimed at developing technologies and approaches to improve patient outcome," said Dr. Aubin. "The research projects announced today seek to offer new therapies and approaches to treat illnesses and diseases, and ultimately offer better quality of life for patients and their families."

Research on nanomedicine and regenerative medicine is designed to prevent disease and improve human health. Nanomedicine delivers medical technologies that detect or function at the molecular level to diagnose and treat disease, while regenerative medicine stimulates the renewal of bodily tissues and organs or restores function through natural and bioengineered means. Various innovations in these areas have helped combat vascular diseases, cancer, diabetes, multiple sclerosis and other chronic diseases. By promoting research in these areas, CIHR and CSA will be moving Canada to the forefront of modern medical research.

"By working together, CIHR and the CSA are supporting scientific research and innovations that have applications for health care on earth and in space and provide real benefits for Canadians," said Mr. Leclerc. "Our hope is that cutting-edge diagnostic tools will improve astronaut health in space and be adapted for the early detection and treatment of disease here on earth."

"We congratulate the talented researchers who are leading the projects and believe their work on integrating new technologies into health research holds the potential to dramatically change the way we diagnose and treat diseases," said Professor Lewis.

The projects underwent a rigorous and competitive peer review process and were selected according to international standards of scientific excellence.

This funding will enable researchers to potentially:

Identify microlesions in multiple sclerosis, using a new tool for quantifying the cause of the disease and how well a treatment is working, Dr. Daniel Côté, Université Laval;
Create personalized nanomedicines that silence cancer-causing genes, Dr. Petier Cullis, University of British Columbia;
Develop microchip-based devices to analyze prostate cancer markers in blood, Dr. Shana Kelley, University of Toronto;
Generate transplantable, insulin-producing cells from stem cells for diabetes, Dr. Timothy Kieffer, University of British Columbia;
Develop innovative sensorimotor rehabilitation approaches for patients with spinal cord injuries or stroke, Dr. Serge Rossignol, Université de Montréal;
Study how novel therapeutic interventions can regenerate blood vessels, Dr. Michael Sefton, University of Toronto; and,
Develop nanotechnology-enabled image-guided methods of diagnosing and treating lung cancer and vascular diseases, Dr. Gang Zheng, University Health Network.

####

About Canadian Institutes of Health Research
For the past 10 years, the Canadian Institutes of Health Research (CIHR) has supported better health and health care for Canadians. As the Government of Canada's health research investment agency, CIHR enables the creation of evidence-based knowledge and its transformation into improved treatments, prevention and diagnoses, new products and services, and a stronger, patient-oriented health-care system. Composed of 13 internationally recognized Institutes, CIHR supports more than 13,600 health researchers and trainees across Canada. www.cihr-irsc.gc.ca

For more information, please click here

Contacts:
CIHR Media Relations
613-941-4563


Follow us on:
Facebook - Health Research in Canada
Twitter - CIHR_IRSC IRSC_CIHR

Copyright © Canadian Institutes of Health Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Watch video about Dr. Kelley's research project

Backgrounder on funded projects

Related News Press

News and information

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

The Hiden EQP Plasma Diagnostic with on-board MCA July 22nd, 2014

Iran to Hold 3rd Int'l Forum on Nanotechnology Economy July 22nd, 2014

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Videos/Movies

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

"Nanocamera" takes pictures at distances smaller than light's own wavelength: How is it possible to record optically encoded information for distances smaller than the wavelength of light? July 17th, 2014

CIQUS researchers develop an extremely simple procedure to obtain nanosized graphenes July 15th, 2014

New particle-sorting method breaks speed records: Discovery could lead to new ways of detecting cancer cells or purifying contaminated water July 1st, 2014

Govt.-Legislation/Regulation/Funding/Policy

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Oregon chemists eye improved thin films with metal substitution: Solution-based inorganic process could drive more efficient electronics and solar devices July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Aerospace/Space

National Space Society Calls For Less US Dependence On Russian Space Technology July 15th, 2014

Motorized Miniature Screw-Actuator Provides 20 nm Resolution, Based on Piezo Effect July 8th, 2014

NSS Pays Tribute to Space Pioneer Frederick I. Ordway III July 7th, 2014

Up in Flames: Evidence Confirms Combustion Theory: Berkeley Lab and University of Hawaii research outlines the story of soot, with implications for cleaner-burning fuels July 1st, 2014

Alliances/Partnerships/Distributorships

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

Haydale and Goodfellow Announce Major Distribution Agreement for Functionalised Graphene Materials July 21st, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

Martini Tech Inc. becomes the exclusive distributor for Yoshioka Seiko Co. porous chucks for Europe and North America July 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE